HIA
ALZN icon

Harbor Investment Advisory’s Alzamend Neuro ALZN Stock Holding History

Harbor Investment Advisory’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 1313
2026
Q1 		$1 Hold
1
– – ﹤0.01% 1230
2025
Q4 		$2 Hold
1
– – ﹤0.01% 1225
2025
Q3 		$2 Hold
1
– – ﹤0.01% 1175
2025
Q2 		$3 Sell
1
-1
-50% -$5 ﹤0.01% 1171
2025
Q1 		$19 Hold
2
– – ﹤0.01% 1167
2024
Q4 		$23 Hold
2
– – ﹤0.01% 1139
2024
Q3 		$34 Hold
2
– – ﹤0.01% 1143
2024
Q2 		$79 Hold
2
– – ﹤0.01% 1272
2024
Q1 		$200 Hold
2
– – ﹤0.01% 1291
2023
Q4 		$178 Hold
2
– – ﹤0.01% 1134
2023
Q3 		$711 Hold
2
– – ﹤0.01% 1110
2023
Q2 		$1.53K Hold
2
– – ﹤0.01% 1236
2023
Q1 		$1.27K Buy
2
+1
+100% +$752 ﹤0.01% 1250
2022
Q4 		$452 Hold
1
– – ﹤0.01% 1287
2022
Q3 		$2K Hold
1
– – ﹤0.01% 1220
2022
Q2 		$1K Hold
1
– – ﹤0.01% 1278
2022
Q1 		$2K Hold
1
– – ﹤0.01% 1238
2021
Q4 		$3K Hold
1
– – ﹤0.01% 1182
2021
Q3 		$3K Buy
+1
New +$5.5K ﹤0.01% 1188

Other funds holding ALZN

KWM
KMT Wealth Management El Segundo, California $118M AUM 26.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Harbor Investment Advisory's ALZN Position: Q2 2026 in Review

Harbor Investment Advisory held its Alzamend Neuro (ALZN) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1313.

Harbor Investment Advisory first reported a position in ALZN in Q3 2021 and has held it in 20 quarters since. The position peaked at $3K in Q4 2021. 5 funds tracked by Wall St. Rank hold ALZN as of Q2 2026.

  • Harbor Investment Advisory held 1 share of Alzamend Neuro worth $1 as of Q2 2026.
  • Harbor Investment Advisory left its Alzamend Neuro share count unchanged in Q2 2026.
  • Alzamend Neuro made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1313 holding.
  • Harbor Investment Advisory first reported a position in Alzamend Neuro in Q3 2021 and has held it in 20 quarters since.
  • Harbor Investment Advisory's Alzamend Neuro position peaked at $3K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Alzamend Neuro as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.